1. Home
  2. LGVN vs PMEC Comparison

LGVN vs PMEC Comparison

Compare LGVN & PMEC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Longeveron Inc.

LGVN

Longeveron Inc.

HOLD

Current Price

$2.79

Market Cap

21.4M

Sector

Health Care

ML Signal

HOLD

Logo Primech Holdings Ltd.

PMEC

Primech Holdings Ltd.

HOLD

Current Price

$0.58

Market Cap

23.4M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
LGVN
PMEC
Founded
2014
1984
Country
United States
Singapore
Employees
N/A
N/A
Industry
Medicinal Chemicals and Botanical Products
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
21.4M
23.4M
IPO Year
2021
2021

Fundamental Metrics

Financial Performance
Metric
LGVN
PMEC
Price
$2.79
$0.58
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
★ $3.00
N/A
AVG Volume (30 Days)
★ 145.0K
91.8K
Earning Date
05-08-2026
07-24-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 50.76
N/A
EPS
N/A
★ N/A
Revenue
★ $709,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$10.81
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$0.48
$0.31
52 Week High
$7.60
$2.44

Technical Indicators

Market Signals
Indicator
LGVN
PMEC
Relative Strength Index (RSI) 40.53 61.61
Support Level $0.61 $0.50
Resistance Level $7.45 $0.81
Average True Range (ATR) 0.42 0.08
MACD -0.58 0.01
Stochastic Oscillator 9.24 68.62

Price Performance

Historical Comparison
LGVN
PMEC

About LGVN Longeveron Inc.

Longeveron Inc is a clinical stage biotechnology company developing regenerative medicines to address unmet medical needs. Its investigational product candidate is laromestrocel. Laromestrocel is a proprietary, scalable, allogeneic cellular therapy that has multiple potential modes of action that include pro-vascular, pro-regenerative, and anti-inflammatory mechanisms that collectively appear to promote tissue repair and healing. It is in clinical development of a single investigational product candidate, laromestrocel, for four potential indications: HLHS, Alzheimer's disease (AD), Pediatric Dilated Cardiomyopathy (pediatric DCM), and Aging-related Frailty. It operates in a single operating segment focused on developing regenerative medicines to address unmet medical needs.

About PMEC Primech Holdings Ltd.

Primech Holdings Ltd is a Singapore-based facilities services and AI robotics group with operations in Singapore and Hong Kong. Through its subsidiaries, the company provides integrated facilities management, cleaning and stewarding services to the public and private sectors, serving airports, educational institutions, healthcare facilities, commercial buildings and hospitality venues. It also develops HYTRON, an autonomous restroom-cleaning robot that uses AI perception and robotic manipulation. In addition, the company operates HomeHelpy, a digital platform for booking home services for consumers.

Share on Social Networks: